» Articles » PMID: 21069937

Relationship Between Target Antigens and Major Histocompatibility Complex (MHC) Class II Genes in Producing Two Pathogenic Antibodies Simultaneously

Overview
Date 2010 Nov 12
PMID 21069937
Citations 8
Authors
Affiliations
Soon will be listed here.
Abstract

In this report,we present 15 patients with histological and immunopathologically proven pemphigus vulgaris (PV). After a mean of 80 months since the onset of disease, when evaluated serologically, they had antibodies typical of PV and pemphigoid (Pg). Similarly, 18 patients with bullous pemphigoid (BP) and mucous membrane pemphigoid (MMP) were diagnosed on the basis of histology and immunopathology.After a mean of 60 months since the onset of disease, when their sera were evaluated they were found to have Pg and PV autoantibodies. In both groups of patients the diseases were characterized by a chronic course, which included several relapses and recurrences and were non-responsive to conventional therapy. The major histocompatibility complex class II (MHC II) genes were studied in both groups of patients and phenotypes associated typically with them were observed. Hence, in 33 patients, two different pathogenic autoantibodies were detected simultaneously. The authors provide a computer model to show that each MHC II gene has relevant epitopes that recognize the antigens associated with both diseases. Using the databases in these computer models, the authors present the hypothesis that these two autoantibodies are produced simultaneously due to the phenomena of epitope spreading.

Citing Articles

A systematic review of the role of interleukin-17 inhibitors in bullous pemphigoid: therapeutic and paradoxical effects.

Heidari N, Hosseini S, Heidari A, Ghane Y, Daneshpazhooh M, Mahmoudi H Arch Dermatol Res. 2025; 317(1):544.

PMID: 40067544 DOI: 10.1007/s00403-025-04052-x.


Ocular cicatricial pemphigoid: is there an association with autoimmune diseases?.

Ringer A, Smichowski A, Gomez R, Virasoro B, Martinez L, Bertiller E Int Ophthalmol. 2024; 44(1):99.

PMID: 38376602 DOI: 10.1007/s10792-024-02939-8.


Strategies to Improve Outcomes of Bullous Pemphigoid: A Comprehensive Review of Clinical Presentations, Diagnosis, and Patients' Assessment.

Ruggiero A, Megna M, Villani A, Comune R, Fabbrocini G, di Vico F Clin Cosmet Investig Dermatol. 2022; 15:661-673.

PMID: 35444441 PMC: 9014958. DOI: 10.2147/CCID.S267573.


The Immunogenetics of Autoimmune Blistering Diseases.

Kneiber D, Kowalski E, Amber K Adv Exp Med Biol. 2022; 1367:173-212.

PMID: 35286697 DOI: 10.1007/978-3-030-92616-8_8.


Multiple autoimmunity and epitope spreading in monozygotic twins.

Avalos-Diaz E, Perez-Perez E, Granados J, Pacheco-Tovar D, Bollain-Y-Goytia-de-la-Rosa J, Herrera-Esparza R J Transl Autoimmun. 2021; 4:100132.

PMID: 34816112 PMC: 8593657. DOI: 10.1016/j.jtauto.2021.100132.


References
1.
Ishii K, Amagai M, Hall R, Hashimoto T, Takayanagi A, Gamou S . Characterization of autoantibodies in pemphigus using antigen-specific enzyme-linked immunosorbent assays with baculovirus-expressed recombinant desmogleins. J Immunol. 1997; 159(4):2010-7. View

2.
. Pemphigus: current concepts. Ann Intern Med. 1980; 92(3):396-405. DOI: 10.7326/0003-4819-92-3-396. View

3.
Amagai M, Tsunoda K, Zillikens D, Nagai T, Nishikawa T . The clinical phenotype of pemphigus is defined by the anti-desmoglein autoantibody profile. J Am Acad Dermatol. 1999; 40(2 Pt 1):167-70. DOI: 10.1016/s0190-9622(99)70183-0. View

4.
Lombardi M, Mercuro O, Ruocco V, Lo Schiavo A, Lombari V, Guerrera V . Common human leukocyte antigen alleles in pemphigus vulgaris and pemphigus foliaceus Italian patients. J Invest Dermatol. 1999; 113(1):107-10. DOI: 10.1046/j.1523-1747.1999.00626.x. View

5.
McCluskey J, Farris A, Keech C, Purcell A, Rischmueller M, Kinoshita G . Determinant spreading: lessons from animal models and human disease. Immunol Rev. 1998; 164:209-29. DOI: 10.1111/j.1600-065x.1998.tb01222.x. View